National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 413 cases where Vaccine is HPV or HPV2 or HPV4 and Patient Died

Case Details

This is page 21 out of 42

Result pages: prev   12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   next


VAERS ID: 350228 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-06-09
Onset:2009-06-12
   Days after vaccination:3
Submitted: 2009-06-25
   Days after onset:13
Entered: 2009-06-26
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1477U / 1 UN / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Asthma, Autopsy, Condition aggravated, Death
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (narrow), Eosinophilic pneumonia (broad), Hypersensitivity (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2009-06-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: hormonal contraceptives (unspecified)
Current Illness:
Preexisting Conditions: Asthma bronchial
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0906USA04039

Write-up: Information has been received from a gynaecologist concerning an approximate 14 year old female patient with a history of bronchial asthma, who was vaccinated with a first dose of GARDASIL (lot # not reported) IM into the upper arm on 09-JUN-2009. On 12-JUN-2009, the patient experienced an asthmatic attack of which she died. The patient had no long-term medication for the asthma but only on occasion. Concomitant medication included hormonal contraceptives (unspecified). Reportedly, an autopsy was performed. The result is not yet known. A causal relation to the GARDASIL vaccine was considered unlikely by the vaccinating physician. Follow-up information received on 22-JUN-2009: Exact birth date, initials, height (158 cm) and weight (50 kg) as well as lot # 1477U, batch # NH25390 were provided. Following information gathered by phone from the reporting physician, the girl experienced the asthmatic attack at home and an emergency doctor was called. He was not able to arrest the attack and resuscitation was unsuccessful. Other business partner''s numbers included: E2009-05085.


VAERS ID: 361121 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2009-10-15
Entered: 2009-10-16
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0910USA00977

Write-up: Information has been received from a nurse practitioners'' patient who heard on radio that "HPV vaccine killed someone in the country". The cause of death was unknown. The reporter was not sure if the vaccine was GARDASIL or CERVARIX. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested.


VAERS ID: 363051 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-09-28
Onset:2009-09-28
   Days after vaccination:0
Submitted: 2009-10-27
   Days after onset:29
Entered: 2009-10-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA043BB / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Cardiac arrest, Circulatory collapse, Death, Malaise, Neoplasm malignant, Ventricular fibrillation
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Ventricular tachyarrhythmias (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Respiratory failure (broad), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2009-09-28
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Propranolol hydrochloride; Lansoprazole; Sumatriptan succinate
Current Illness: Unknown
Preexisting Conditions: No known allergies. Was being treated for migraines with propranolol (unknown dose or presentation) but this has not been confirmed by patient''s GP or family.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0595286A

Write-up: This case was reported by a physician and described the occurrence of death nos in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On the morning of the 28 September 2009 the patient received unspecified dose of CERVARIX (1 injection). On 28 September, within 30 minutes after vaccination with CERVARIX, the patient experienced a possible anaphylactic reaction (not confirmed). The patient collapsed and had to be administered an adrenaline injection. The patient had to be resuscitated by the paramedics and was taken to accident and emergency where they made another attempt to resuscitate the patient. The attempt was not successful and the patient was declared dead on 28 September 2009. It was unknown whether an autopsy was performed. Verbatim text: On the 28th September 2009 a public health consultant reported that a 14 year old female patient was administered a dose of CERVARIX ( Batch: AHPVA043BB, expiry: 09/2010) at school, in the morning of the 28th September 2009 as part of a school immunization program. The consultant reported that within 30 minutes after the administration of the CERVARIX the patient experienced what they believed was an anaphylactic reaction (not confirmed). The patient collapsed and had to be administered an adrenaline injection, she had to be resuscitated by paramedics and was taken to accident and emergency where they made another attempt to resuscitate the patient but it was not successful and the patient was declared dead. There was no further information available at the time of reporting. Follow-up information received via regulatory authority on 30 September 2009: The patient was taking CERVARIX for the prevention of premalignant cervical lesions and cervical cancer. The patient had no known allergies. She was being treated for migraines with propranolol (unknown dose or presentation) but his has not been confirmed by patient''s GP or family. The patient received her first dose of CERVARIX (Batch Number: A1-IPVA043BB) at 10:45 on Monday 28th September 2009 and following complaining of being unwell, had collapsed at approximately 12:00. Paramedics performed CPR on the patient but could not revive her and following further unsuccessful resuscitation attempts at the local acute trust Emergency Care Department, was pronounced dead. The patient died on 28 September 2009 from anaphylaxis. Follow-up information received on 8 October 2009: On 28 September 2009 the subject experienced circulatory collapse. The cause of death was unknown. Follow-up information received on 9 October 2009: Concurrent medications included lansoprazole and sumatriptan succinate. On the morning of the 28 September 2009 the subject received an unspecified dose of CERVARIX (1 injection, intramuscular). The reporter stated that it was not possible to confirm whether the subject was actually administered a dose of sumatriptan succinate prior to vaccination with CERVARIX. The regulatory authority reported that the subject ''received the vaccination, collapsed approximately 60 minutes later, VF, then asystolic arrest. No external signs of anaphylaxis.'' The cause of death was reported to be anaphylaxis. Follow-up information received on 16 October 2009: On an unknown date the subject experienced a malignant neoplasm. The outcome of the malignant neoplasm was fatal. The cause of death was reported to be malignant neoplasm. Post mortem results were pending.


VAERS ID: 372910 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Foreign  
Vaccinated:2008-09-18
Onset:2009-09-22
   Days after vaccination:369
Submitted: 2009-12-10
   Days after onset:79
Entered: 2009-12-11
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2009-09-22
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Herpes virus infection
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0912USA00953

Write-up: Information has been received from the agency via Case Line listing via CSL, as part of a business agreement, concerning an 18 year old female patient with disseminated herpes viral disease who on 17-MAR-2009 was vaccinated with the third dose of GARDASIL (batch #NJ11440, lot# 1283U). The second suspect therapy included DEPO-PROVERA which was administered IM, 600 mg yearly, from 2007 October to 2009 January. On 22-SEP-2009 the patient developed sudden death (severe). It was unknown if the patient sought medical attention. A lot check has been initiated. No further information is available.


VAERS ID: 374780 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2009-12-21
Entered: 2009-12-22
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Autoimmune disorder, Death
SMQs:, Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0912USA02326

Write-up: Information was reported in a newspaper article that a 14 year old female patient who on an unspecified date was vaccinated with a dose of GARDASIL vaccine (lot number, date, route and site not reported). Subsequently the patient experienced auto-immune symptoms and died 21 months later. The article also discussed the multiple sclerosis of other 5 patient while on therapy with GARDASIL vaccine (WAES 0912USA01664, WAES 0912USA02322, WAES 0912USA02323, WAES 0912USA02324, and WAES 0912USA02325, WAES 0912USA02639, WAES 0912USA02640, WAES 0912USA02641, WAES 0912USA02642 and WAES 0912USA02643. No further information is available.


VAERS ID: 375036 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Foreign  
Vaccinated:2007-05-22
Onset:2007-07-11
   Days after vaccination:50
Submitted: 2009-12-23
   Days after onset:896
Entered: 2009-12-24
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0859F / 1 UN / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Autopsy, Death, Osteitis
SMQs:, Osteonecrosis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2007-07-15
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: VALETTE
Current Illness:
Preexisting Conditions: none
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0912USA02946

Write-up: Information has been received from a physician concerning a previous healthy 17 year old female patient with no relevant medical history who on 22-MAY was vaccinated intramuscularly with her first dose of GARDASIL (Lot # 654740/0859F) (Batch # NE29660) (Injection site was not reported). Concomitant therapy included VALETTE. On 11-JUL-2007 the reporter was informed by the patient''s mother that her daughter was hospitalized due to bone inflammation. On 15-JUL-2007, approximately 7 weeks post vaccination, the patient died of unknown cause. An autopsy was carried out, but the result was not known to the reporter up to the time of reporting. A lot check has been initiated. Other business partner numbers include E2009-11667. Additional information has been requested.


VAERS ID: 378500 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-10-14
Onset:2009-10-15
   Days after vaccination:1
Submitted: 2010-01-27
   Days after onset:104
Entered: 2010-01-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA050AG / 2 AR / IM

Administered by: Other       Purchased by: Other
Symptoms: Death, General physical health deterioration, Headache, Impaired work ability, Loss of consciousness, Malaise, Pain in extremity, Pyrexia, Respiratory failure, Snake bite
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2009-11-02
   Days after onset: 18
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Joint pain
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0628298A

Write-up: This case was reported by a physician and described the occurrence of respiratory failure in a 15-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included joints pain. Previous and/or concurrent vaccination included CERVARIX ;GlaxoSmithKline;intramuscular;unknown deltoid given on 9 September 2009. On 14 October 2009, the subject received 2nd dose of CERVARIX (intramuscular, unknown deltoid). The subject was put under observation during 30 minutes after both vaccinations. No adverse event had occurred. On 15 October 2009, 1 day after vaccination with CERVARIX, the subject experienced a low grade fever and headache. She visited an homeopathy center where she was prescribed treatment with paracetamol, Liv 52 and RANTAC. The subject was advised to come back to the center for follow-up after 2 days of treatment. The events resolved and the subject restarted her daily chores. On 1st November 2009, the subject informed her parents that an insect has bitten her during the field work. She was not feeling well and complained about leg pain. Post noon, the subject didn''t go to work and rested at home. Overnight, her condition deteriorated. On the morning of the 2nd November 2009, an ambulance was called. The subject''s vital signs recorded at the time of shifting were poor. On the way to hospital, she became unconscious and her vital signs were not recordable. The cardio pulmonary resuscitation provided was unsuccessful. At hospital, she was declared dead due to a respiratory failure. Autopsy was rejected by the family. The physician considered the events were unrelated to vaccination with CERVARIX and so, no follow-up was necessary. The subject died on 2 November 2009 from a suspected snake bite. An autopsy was not performed.


VAERS ID: 379570 (history)  
Form: Version 1.0  
Age: 12.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-07-20
Onset:2009-09-06
   Days after vaccination:48
Submitted: 2010-02-04
   Days after onset:151
Entered: 2010-02-05
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Death, Drowning, Fall
SMQs:, Accidents and injuries (narrow), Hostility/aggression (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES1001USA03763

Write-up: Information has been received from from a physician concerning a 12 year old school going girl of class eight of a village. On 20-JUL-2009, the patient received first dose of GARDASIL in the school. During the process of community mobilization for second dose of GARDASIL, the female health worker was informed that on 06-SEP-2009, the patient accidentally fell in open well (granite quarry filled with water), drowned and expired. This event occurred 49 days of receiving first dose of GARDASIL. The female health worker informed the Medical Officer in-charge, which was then communicated to District Immunization Officer. The medical officer in-charge investigated the death and completed first information report and determined that death was not related to the vaccine.


VAERS ID: 379874 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-07-16
Onset:2009-08-29
   Days after vaccination:44
Submitted: 2010-02-08
   Days after onset:163
Entered: 2010-02-09
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 LA / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Completed suicide, Death, Poisoning
SMQs:, Suicide/self-injury (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2009-08-29
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES1001USA03762

Write-up: Information has been received from a physician concerning a 14 year old school going girl (ID#: -3/09) who received the first dose of GARDASIL in left deltoid, on 16-JUL-2009. Concomitant therapy included indigo. During the process of community mobilization for second dose, the female health worker was informed that the patient committed suicide on 29-AUG-2009 by consuming insecticide. The postmortem was performed on 30-AUG-2009. This event occurred after 45 days of receiving first dose of GARDASIL. The female health worker informed the medical officer in charge, which was then communicated to Immunization Officer. The medical officer in charge investigated the death and completed first information report as per guidelines and determined the death was not related to the vaccine and so no further investigations were done. No further information is available.


VAERS ID: 379876 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-07-19
Onset:2010-01-21
   Days after vaccination:186
Submitted: 2010-02-08
   Days after onset:18
Entered: 2010-02-09
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Completed suicide, General physical health deterioration, Poisoning deliberate
SMQs:, Suicide/self-injury (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES1002USA00379

Write-up: Information has been received from a physician concerning a 13 year old school going girl (ID#: -104/09) of class eight. On 19-JUL-2009, patient received first dose of GARDASIL left deltoid (lot#876, manufacturing date June 2008). Patient successfully completed her second dose on 13-OCT-2009. She was due with her third dose. On 21-JAN-2010, she was reported to have consumed poison around 9:00 am. She was taken to the area hospital and provided preliminary emergency treatment. She was provided DECADRON injection 2 cc, injection dopamine 1 amp. in 5% dextrose 10-12 drops/min, injection deriphylline I.V 8 hourly, injection diazepam 1 amp. IV, Ryle''s tube aspiration and stomach wash. It was advised to record her temperature, pulse, respiration, and blood pressure half hourly and had oxygen inhalation. High risk consent was taken. As her condition started to deteriorate she was shifted to another hospital by ''108 emergency service'' for further evaluation and management. On the way to the hospital, it was reported to have expired around 2:00 pm on 21-JAN-2010. The hospital noted the case was "brought dead". The postmortem was performed on 22-JAN-2010 and the results are awaited. The medical officer in charge investigated the death and completed first information report and determined the death could be suicide (due to poison intake) and not related to the vaccine. This report was part of a post-marketing surveillance program.


Result pages: prev   12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=21&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4&DIED=Yes


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166